#animalrights stop #animaltestings by
Please set the Beagles free! Sign the petition!!
28th of December, 2012: AstraZeneca denies that they are planning a mass killing and says that they plan to send the dogs to their laboratories in the UK for further painful experiments - a fate that is in fact worse than death!
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biologics company headquartered in London, United Kingdom. It is the world's fifth-largest pharmaceutical company measured by 2009 prescription drug sales (after Pfizer, Novartis, Sanofi, and GlaxoSmithKline) and has operations in over 100 countries. It has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.
Astra AB was founded in 1913 in Södertälje, Sweden, by 400 doctors and apothecaries. In 1993 the British chemicals company ICI demerged its pharmaceuticals businesses and its agrochemicals and specialties businesses, to form Zeneca Group plc, and in 1999 Astra and Zeneca Group merged to form AstraZeneca plc.
In 2005 the company announced that it had become a Diamond Member of the Pennsylvania Bio commerce organisation.It also decided to acquire KuDOS Pharmaceuticals, a UK biotech company, for £120m and entered into an anti-cancer collaboration agreement with Astex.
In 2006, following a collaborative relationship begun in 2004, AstraZeneca acquired Cambridge Antibody Technology for £702 million.
In February 2007 AstraZeneca agreed to buy Arrow Therapeutics, a company focused on the discovery and development of anti-viral therapies, for $150 million.
In 2011 AstraZeneca acquired Guangdong BeiKang Pharmaceutical Company, a Chinese generics business.
In February 2012 AstraZeneca and Amgen announced collaboration on treatments for inflammatory diseases.Then in April 2012, AstraZeneca acquired Ardea Biosciences, another biotechnology company, for $1.26 billion.
In February 2012, Swedish newspapers announced that Anglo-Swedish pharmaceuticals giant AstraZeneca is closing its research facilities in Södertälje, south of Stockholm, as part of a major restructuring, resulting in the loss of around 1,000 Swedish jobs. Over the past two years, the big pharmaceutical giant divested much of its operations in Sweden and this has also affected their laboratory facilities and experimental animal activities.
In June 2012 AstraZeneca and Bristol-Myers Squibb announced a two-stage deal for the joint acquisition of the biotechnology company Amylin Pharmaceuticals. It was agreed that Bristol-Myers Squibb would acquire Amylin for $5.3 billion in cash and the assumption of $1.7 billion in debt, with AstraZeneca then paying $3.4 billion in cash to Bristol-Myers Squibb, and Amylin being folded into an existing diabetes joint-venture between AstraZeneca and Bristol-Myers Squibb.
Experiments conducted on animals:
Like every pharmaceutical company, AstraZeneca conducts experiments on animals. According to AstraZeneca's own website, in 2011 AstraZeneca has used approximately 398,000 animals, including those used by external contract research organisations on their behalf. Approximately 76% (302,480) were rodents, 22% (87,560) were fish and the remaining 2% (7,960) included chickens, dogs, rabbits, ferrets, primates, pigs, goats and sheep.
In 2010, AstraZeneca "used" 429,000 animals and in 2009, 410,000 animals were "used" for the purpose of testings and experiments.